All’s fair in Drugs and War

======================================
GlaxoSmithKline
======================================
$3 BILLION
——————————————————————
7/2/2012
——————————————————————
(4/1998 – 8/2003)
——————————————————————
United States alleges GSK participated in
preparing
publishing
distributing

misleading medical journal article that misreported that clinical trial of drug demonstrated efficacy in treatment when study failed to demonstrate efficacy
——————————————————————
At same time, United States alleges, GSK didn’t make available data from 2 other studies in which drug also failed to demonstrate efficacy
——————————————————————
(2001 – 2007)
——————————————————————
United States alleges GSK failed to include certain safety data about drug in reports to FDA meant to allow FDA to determine if drug continues to be safe for approved indications and to spot drug safety trends
——————————————————————
missing information included data regarding certain post-marketing studies
——————————————————————
data regarding 2 studies undertaken in response to European regulators’ concerns about safety of drug
——————————————————————
United States alleges GSK stated drug had positive cholesterol profile despite having no well-controlled studies to support that message
======================================

======================================
Johnson & Johnson (J&J) and subsidiaries, Janssen Pharmaceuticals Inc. and Scios Inc.
Janssen Pharmaceutica Products, L.P.
======================================
$2.2 BILLION +
——————————————————————
11/4/2013, Monday
——————————————————————
Johnson & Johnson (J&J) and Janssen
——————————————————————
complaint alleges J&J and Janssen were aware drug posed serious health risks, but companies downplayed these risks
——————————————————————
For example, when J&J study of drug showed significant risk of strokes and other adverse events in patients, complaint alleges Janssen combined study data with other studies to make it appear there was lower overall risk of adverse events
——————————————————————
year after J&J received results of 2nd study confirming increased safety risk for patients taking drug, but hadn’t published data, one physician who worked on study cautioned Janssen
——————————————————————
“[a]t this point, so long after [the study] has been completedwe must be concerned that this gives the strong appearance that Janssen is purposely withholding the findings.”
——————————————————————
complaint alleges Janssen knew patients taking drug had increased risk, but nonetheless promoted drug as “uncompromised by safety concerns
——————————————————————
When Janssen received initial results of studies indicating drug posed same risk as other antipsychotics, complaint alleges company retained outside consultants to re-analyze study results and ultimately published articles stating drug was actually associated with lower risk
——————————————————————
J&J and another of its subsidiaries, Scios Inc.
——————————————————————
8/2001 – FDA approved drug to treat patients with acutely decompensated congestive heart failure who have shortness of breath at rest or with minimal activity
——————————————————————
approval based on study involving hospitalized patients experiencing severe heart failure who received infusions of drug over average 36-hour period
——————————————————————
complaint alleged Scios had no sound scientific evidence supporting medical necessity of outpatient infusions and misleadingly used small pilot study to encourage serial outpatient use of drug
======================================

======================================
Abbott Laboratories Inc.
======================================
$1.5 BILLION
——————————————————————
5/7/2012, Monday
——————————————————————
(2001 – 2006)
——————————————————————
company marketed drug in combination with atypical antipsychotic drugs even after its clinical trials failed to demonstrate adding drug was any more effective than atypical antipsychotic alone for that use
——————————————————————
1999 – forced to discontinue clinical trial of drug due to increased incidence of adverse events, including
somnolence
dehydration
anorexia
experienced by study participants administered drug
——————————————————————
funded 2 studies of use of drug
both failed to meet main goals established for the study
——————————————————————
When 2nd study failed to show statistically significant treatment difference between antipsychotic drugs used in combination with drug and antipsychotic drugs alone, waited nearly 2 years to notify sales force about study results and another 2 years to publish results
======================================

======================================
AstraZeneca LP / AstraZeneca Pharmaceuticals LP
======================================
$520 MILLION
——————————————————————
4/27/2010, Tuesday
——————————————————————
engaged doctors to conduct studies on unapproved uses of drug
——————————————————————
recruited doctors to serve as authors of articles that were ghostwritten by medical literature companies and about studies doctors in question didn’t conduct
——————————————————————
then used
studies
articles

as basis for promotional messages about unapproved uses of drug
======================================
REFERENCE:
======================================
11/26/2013 – United States Department of Justice (DOJ) versus BIG Pharma: BIG Pharma fought the law, and the law won ?:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/11/26/united-states-department-of-justice-versus-big-pharma-big-pharma-fought-the-law-and-the-law-won/
======================================

Advertisement

The War on Cancer (I don’t think it means, what you think it says it means) #Winning?

“In 1971, the ACS (American Cancer Society) aggressively campaigned President Nixon to declare the “War on Cancer,” claiming that this could be won, given increased funding for the National Cancer Institute (NCI)

“President Nixon responded by increasing its funding by $200,000”

“This was in excess of the funding that it then received as one of 30 other National Institutes of Health”

“In so doing, President Nixon effectively created an independent status for the NCI [0]
——————————————————————
American Cancer Society
——————————————————————
Cancer Facts & Figures 2002-2013
——————————————————————
Expected New Cancer Cases – USA
——————————————————————
2013☝1,660,290 – (21,380 more than 2012)
2012☝1,638,910 – (42,240 more than 2011)
2011☝1,596,670 – (67,160 more than 2010)
2010☝1,529,560 – (49,810 more than 2009)
2009☝1,479,350 – (42,170 more than 2008)

2008👇1,437,180 – ( 7,740 less than 2007)
2007☝1,444,920 – (45,130 more than 2006)
2006☝1,399,790 – (26,880 more than 2005)
2005☝1,372,910 – ( 4,870 more than 2004)
2004☝1,368,030 – (33,930 more than 2003)
2003☝1,334,100 – (49,200 more than 2002)
2002
1,284,900
——————————————————————
Expected to Die – United States
——————————————————————
2013☝580,350_-_(3,160 more than 2012)
2012☝577,190
_-_(5,240 more than 2011)
2011☝571,950
_-_(2,460 more than 2010)
2010☝569,490
_-_(7,150 more than 2009)
2009👇562,340_-_(3,310 less than 2008)
2008☝565,650_-_(6,000 more than 2007)
2007👇559,650_-_(5,180 less than 2006)
2006👇564,830_-_(5,450 less than 2005)
2005☝570,280_-_(6,580 more than 2004
2004☝563,700
_-_(7,200 more than 2003)
2003☝556,500
_-_(6,000 more than 2002)
2002
_-_555,500
——————————————————————
Deaths – United States of America
——————————————————————
2013almost 1,600 a day
2012 – 1,500+ a day
2011 – 1,500+ a day
2010 – 1,500+ a day
2009 – 1,500+ a day
2008 – 1,500+ a day
2007 – 1,500+ a day
2006 – 1,500+ a day
2005 – 1,500+ a day
2004 – 1,500+ a day
2003 – 1,500+ a day
======================================
Estimated Childhood Cancer Deaths (0-14 years)
——————————————————————
2013👇1, 310
2012☝1,340
2011👇1,320
2010👇1,340
2009👇1,380
2008👇1,490
2007👇1,545
2006👇1,560
2005☝1,585
2004☝1,510
2003☝1,500
2002
1,400
——————————————————————
Estimated New Childhood Cancer (0-14 years)
——————————————————————
2013👇11,630
2012☝12,060
2011☝11,210

2010👇10,700
200910,730
2008☝10,730
2007☝10,400

2006👇9,500
2005☝9,510
2004☝9,200

2003👇9,000
20029,100
======================================
Estimated Brain and other nervous system Cancer Deaths (Women)
——————————————————————
2013☝6,150 (2%)
2012☝5,980 (2%)

2011👇5,670 (2%)
2010☝5,720 (2%)
2009👇5,590 (2%)
2008☝5,650 (2%)
2007☝5,590 (2%)
2006☝5,560 (2%)

2005👇5,480 (2%)
2004👇5,490 (2%)
2003👇5,800 (2%)
20025,900 (2%)
======================================
Estimated All Cancer Deaths (Women)
——————————————————————
2013👇273,430 (100%)
2012☝275,370 (100%)
2011☝271,520 (100%)
2010☝270,290 (100%)

2009👇269800 (100%)
2008☝271,530 (100%)
2007👇270,100 (100%)
2006👇273,560 (100%)
2005☝275,000 (100%)
2004☝272,810 (100%)
2003☝270,600 (100%)
2002
_-_267,300 (100%)
——————————————————————
Estimated Lung and bronchus Cancer Deaths (Women)
——————————————————————
2013👇72,220 (26%)
2012☝72,590 (26%)
2011☝71,340 (26%)
2010☝71,080 (26%)

2009👇70,490 (26%)
2008☝71,030 (26%)
2007👇70,880 (26%)
2006👇72,130 (26%)
2005☝73,020 (27%)
2004👇68,510 (25%)
2003☝68,800 (25%)
2002
65,700 (25%)
——————————————————————
Estimated Breast Cancer Deaths (Women)
——————————————————————
2013☝39,620 (14%)
2012👇39,510 (14%)
2011👇39,520 (15%)
2010👇39,840 (15%)
2009👇40,170 (15%)
2008☝40,480 (15%)
2007👇40,460 (15%)
2006☝40,970 (15%)
2005👇40,410 (15%)
2004☝40,110 (15%)
2003☝39,800 (15%)
2002
39,600 (15%)
——————————————————————
Estimated Colon and rectum Cancer Deaths (Women)
——————————————————————
2013👇24,530 (9%)
2012☝25,220 (9%)
2011👇24,130 (9%)
2010👇24,790 (9%)
2009👇24,680 (9%)
2008👇25,790 (9%)
2007👇26,180 (10%)
2006👇27,300 (10%)
2005👇27,750 (10%)
2004👇28,410 (10%)
200328,800 (11%)
2002
28,800 (11%)
——————————————————————
Estimated Pancreas Cancer Deaths (Women)
——————————————————————
2013☝18,970 (7%)
2012☝18,540 (7%)
2011☝18,300 (7%)
2010☝18,030 (7%)
2009☝17,210 (6%)
2008☝16,790 (6%)
2007☝16,530 (6%)
2006☝16,210 (6%)
2005☝15,980 (6%)
2004☝15,830 (6%)
2003☝15,300 (16%)
2002
15,200 (16%)
——————————————————————
Estimated Ovary Cancer Deaths (Women)
——————————————————————
2013👇14,030 (5%)
2012☝15,500 (6%)
2011☝15,460 (6%)

2010👇13,850 (5%)
2009👇14,600 (5%)
2008☝15,520 (6%)
2007👇15,280 (6%)
2006👇15,310 (6%)
2005☝16,210 (6%)
2004☝16,090 (6%)
2003☝14,300 (5%)
2002
13,900 (5%)
——————————————————————
Estimated Leukemia Deaths (Women)
——————————————————————
2013☝10,060 (4%)
2012☝10,040 (4%)

2011👇9,040 (3%)
2010👇9,180 (3%)
2009☝9,280 (3%)
2008👇9,250 (3%)
2007👇9,470 (4%)
2006👇9,810 (4%)
2005👇10,030 (4%)
2004☝10,310 (4%)
2003☝9,800 (4%)
2002
9,600 (4%)
——————————————————————
Estimated Non-Hodgkin lymphoma Deaths (Women)
——————————————————————
2013👇8,430 (3%)
2012👇8,620 (3%)
2011☝9,570 (4%)
2010👇9,500 (4%)
2009☝9,670 (4%)
2008☝9,370 (3%)
2007☝9,060 (3%)

2006👇8,840 (3%)
2005☝9,050 (3%)
2004👇9,020 (3%)
2003👇11,200 (4%)
200211,700 (4%)
——————————————————————
Estimated Uterine corpus Cancer Deaths (Women)
——————————————————————
2013☝8,190 (3%)
2012👇8,010 (3%)
2011☝8,120 (3%)
2010☝7,950 (3%)
2009☝7,780 (3%)
2008☝7,470 (3%)
2007☝7,400 (3%)
2006☝7,350 (3%)
2005☝7,310 (3%)
2004☝7,090 (3%)
2003☝6,800 (3%)
2002
6,600 (2%)
——————————————————————
Estimated Liver and intrahepatic bile duct Cancer Deaths (Women)
——————————————————————
2013☝6,780 (2%)
2012☝6,570 (2%)
2011☝6,330 (2%)
2010☝6,190 (2%)
2009☝6,070 (2%)
2008☝5,840 (2%)
2007
5,500 (2%)
2006
2005
2004
2003
2002
——————————————————————
Estimated Multiple myeloma Cancer Deaths (Women)
——————————————————————
2013
2012
2011
2010
2009
2008
2007
2006👇5,630 (2%)
20055,640 (2%)
2004☝5,640 (2%)
2003☝5,500 (2%)
2002
5,300 (2%)
======================================
Estimated New Cancer All (Women)
——————————————————————
2013☝805,500 (100%)
2012☝790,740 (100%)
2011☝774,370 (100%)
2010☝739,940 (100%)
2009☝713,220 (100%)
2008☝692,000 (100%)

2007👇678,060 (100%)
2006☝679,510 (100%)
2005👇662,870 (100%)
2004☝668,470 (100%)
2003☝658,800 (100%)
2002
_-_647,400 (100%)
——————————————————————
Estimated New Breast Cancer (Women)
——————————————————————
2013☝232,340 (29%)
2012👇226,870 (29%)
2011☝238,480 (30%)
2010☝207,090 (28%)
2009☝192,370 (27%)
2008☝182,460 (26%)

2007👇178,480 (26%)
2006☝212,920 (31%)
2005👇211,240 (32%)
2004☝215,900 (32%)
2003☝211,300 (32%)
2002
_-_203,500 (31%)
——————————————————————
Estimated New Lung and bronchus Cancer (Women)
——————————————————————
2013☝110,110 (14%)
2012☝109,690 (14%)
2011☝106,070 (14%)
2010☝105,770 (14%)
2009☝103,350 (14%)
2008☝100,330 (14%)
2007☝98,620 (15%)
2006☝81,770 (12%)

2005👇79,560 (12%)
2004☝80,660 (12%)
2003☝80,100 (12%)
2002
79,200 (12%)
——————————————————————
Estimated New Colon and rectum Cancer (Women)
——————————————————————
2013👇69,140 (9%)
2012☝70,040 (9%)
2011👇69,360 (9%)
2010👇70,480 (10%)
2009👇71,380 (10%)
2008👇71,560 (10%)
2007👇74,630 (11%)
2006☝75,810 (11%)
2005☝73,470 (11%)

2004👇73,320 (11%)
2003👇74,700 (11%)
200275,700 (12%)
——————————————————————
Estimated New Uterine corpus Cancer (Women)
——————————————————————
2013☝49,560 (6%)
2012☝47,130 (6%)
2011☝46,470 (6%)
2010☝43,470 (6%)
2009☝42,160 (6%)
2008☝41,100 (6%)

2007👇39,080 (6%)
2006☝41,200 (6%)
2005☝40,880 (6%)

2004👇40,320 (6%)
2003☝41,00 (6%)
2002
39,300 (6%)
——————————————————————
Estimated New Thyroid Cancer (Women)
——————————————————————
2013☝45,310 (6%)
2012☝43,210 (5%)
2011☝36,550 (5%)
2010☝33,930 (5%)

2009👇27,200 (4%)
2008☝28,410 (4%)
2007☝25,480 (4%)
2006☝22,590 (3%)
2005☝19,190 (3%)
2004☝17,640 (3%)
2003☝16,300 (3%)
2002
15,800 (2%)
——————————————————————
Estimated New Non-Hodgkin lymphoma (Women)
——————————————————————
2013☝32,140 (4%)
2012☝31,970 (4%)
2011☝30,300 (4%)
2010☝30,160 (4%)

2009👇29,990 (4%)
2008☝30,660 (4%)
2007☝28,990 (4%)
2006☝28,190 (4%)
2005☝27,320 (4%)
2004☝25,520 (4%)

2003👇25,100 (4%)
200225,700 (4%)
——————————————————————
Estimated New Melanoma of the skin Cancer (Women)
——————————————————————
2013👇31,630 (4%)
2012☝32,000 (4%)
2011☝30,220 (4%)

2010👇29,260 (4%)
2009☝29,640 (4%)
2008☝27,530 (4%)

2007👇26,030 (4%)
2006☝27,930 (4%)
2005☝26,000 (4%)
2004☝25,200 (4%)
2003☝24,300 (3%)
2002
23,500 (4%)
——————————————————————
Estimated New Kidney and renal pelvis Cancer (Women)
——————————————————————
2013☝24,720 (3%)
2012☝24,520 (4%)
2011☝23,800 (3%)
2010☝22,870 (3%)
2009☝22,330 (3%)
2008☝21,260 (3%)
2007
19,600 (3%)
2006
2005
2004
2003
2002
——————————————————————
Estimated New Pancreas Cancer (Women)
——————————————————————
2013☝22,489 (3%)
2012👇21,830 (3%)
2011☝21,980 (3%)
2010☝21,770 (3%)
2009 21,420 (3%)

2008
2007
2006☝16,580 (2%)
2005👇16,080 (2%)
2004☝16,120 (2%)
2003☝15,800 (2%)
2002
15,600 (2%)
——————————————————————
Estimated New Ovary Cancer (Women)
——————————————————————
2013👇22,240 (3%)
2012☝22,280 (3%)
2011☝21,990 (3%)
2010☝21,880 (3%)

2009👇21,550 (3%)
2008👇21,650 (3%)
2007☝22,430 (3%)
2006👇20,180 (3%)
2005👇22,220 (3%)
2004☝25,580 (4%)
2003☝25,400 (4%)
2002
23,300 (4%)
——————————————————————
Estimated New Leukemia (Women)
——————————————————————
2013
2012
2011
2010
2009
2008👇19,090 (3%)
200719,440 (3%)
2006
2005
2004
2003
2002
——————————————————————
Estimated New Urinary bladder Cancer (Women)
——————————————————————
2013
2012
2011
2010
2009
2008
2007
2006☝16,730 (2%)
2005☝16,200 (2%)
2004☝15,600 (2%)
2003
15,200 (2%)
2002
15,200 (2%)
======================================
Estimated All Cancer Deaths (Men)
——————————————————————
2013☝306,920 (100%)
2012☝301,820 (100%)
2011☝300,430 (100%)
2010☝299,200 (100%)

2009👇292,540 (100%)
2008☝294,120 (100%)
2007👇289,550 (100%)
2006👇291,270 (100%)
2005☝295,280 (100%)
2004☝290,890 (100%)

2003👇285,900 (100%)
2002_-_288,200 (100%)
——————————————————————
Estimated Lung and bronchus Deaths (Men)
——————————————————————
2013👇87,260 (28%)
2012☝87,750 (29%)
2011👇85,600 (28%)
2010👇86,220 (29%)
2009👇88,900 (30%)
2008☝98,810 (31%)
2007👇89,510 (31%)
2006👇90,330 (31%)
2005👇90,490 (31%)
2004☝91,930 (32%)
2003👇88,400 (31%)
200289,200 (31%)
——————————————————————
Estimated Prostate Cancer Deaths (Men)
——————————————————————
2013☝29,720 (10%)
2012👇28,170 (9%)
2011☝33,720 (11%)
2010☝32,050 (11%)

2009👇27,360 (9%)
2008☝28,660 (10%)
2007👇27,050 (9%)
2006👇27,350 (9%)
2005☝30,350 (10%)
2004☝29,500 (10%)

2003👇28,900 (10%)
200230,200 (11%)
——————————————————————
Estimated Colon and rectum Cancer Deaths (Men)
——————————————————————
2013👇26,300 (9%)
2012☝26,470 (9%)
2011👇25,250 (8%)
2010☝26,580 (9%)
2009☝25,240 (9%)

2008👇24,260 (8%)
2007👇26,000 (9%)
2006👇27,870 (10%)
2005☝28,540 (10%)
2004☝28,320 (10%)
2003☝28,300 (10%)
2002
27,800 (10%)
——————————————————————
Estimated Pancreas Cancer Deaths (Men)
——————————————————————
2013☝19,480 (6%)
2012👇18,850 (6%)
2011☝19,360 (3%)
2010☝18,770 (6%)
2009☝18,030 (6%)
2008☝17,500 (6%)
2007☝16,840 (6%)
2006☝16,090 (6%)
2005☝15,820 (5%)
2004☝15,440 (5%)
2003☝14,700 (5%)
2002
14,500 (5%)
——————————————————————
Estimated Liver and intrahepatic bile duct Cancer Deaths (Men)
——————————————————————
2013☝14,890 (5%)
2012☝13,980 (5%)
2011☝13,260 (4%)
2010☝12,720 (4%)

2009👇12,090 (4%)
2008☝12,570 (4%)
2007☝11,280 (4%)
2006☝10,840 (4%)
2005☝10,330 (3%)
2004☝9,450 (3%)
2003☝9,200 (3%)
2002
8,900 (3%)
——————————————————————
Estimated Leukemia Deaths (Men)
——————————————————————
2013☝13,660 (4%)
2012☝13,500 (4%)
2011☝12,740 (4%)
2010☝12,660 (4%)
2009☝12,590 (4%)
2008☝12,460 (4%)

2007👇12,320 (4%)
2006👇12,470 (4%)
2005👇12,540 (4%)
2004☝12,990 (5%)
2003
12,100 (4%)
2002
12,100 (4%)
——————————————————————
Estimated Esophagus Cancer Deaths (Men)
——————————————————————
2013☝12,220 (4%)
2012☝12,040 (4%)
2011☝11,910 (4%)
2010☝11,650 (4%)
2009☝11,490 (4%)
2008☝11,250 (4%)
2007☝10,900 (4%)
2006☝10,730 (4%)
2005☝10,530 (4%)
2004☝10,250 (4%)
2003☝9,900 (4%)
2002
9,600 (3%)
——————————————————————
Estimated Urinary bladder Cancer Deaths (Men)
——————————————————————
2013☝10,820 (4%)
2012👇10,510 (3%)
2011☝10,670 (4%)
2010☝10,410 (3%)
2009☝10,180 (3%)
2008☝9,950 (3%)
2007☝9,630 (3%)
2006☝8,990 (3%)
2005☝8,970 (3%)
2004☝8,780 (3%)
2003
8,600 (3%)
2002
8,600 (3%)
——————————————————————
Estimated Non-Hodgkin lymphoma Deaths (Men)
——————————————————————
2013☝10,590 (3%)
2012☝10,320 (3%)

2011👇9,750 (3%)
2010☝10,710 (4%)
2009☝9,830 (3%)
2008☝9,790 (3%)

2007👇9,600 (3%)
2006👇10,000 (3%)
2005👇10,150 (3%)
2004👇10,390 (4%)
2003👇12,200 (4%)
200212,700 (5%)
——————————————————————
Estimated Kidney and renal pelvis Cancer Deaths (Men)
——————————————————————
2013☝8,780 (3%)
2012☝8,650 (3%)
2011☝8,270 (3%)
2010☝8,210 (3%)
2009☝8,160 (3%)
2008☝8,100 (3%)

2007👇8,080 (3%)
2006☝8,130 (3%)
2005☝8,020 (3%)
2004☝7,870 (3%)
2003☝7,409 (3%)
2002
7,200 (3%)
======================================
Estimated New Cancer All (Men)
——————————————————————
2013☝854,790 (100%)
2012☝848,170 (100%)
2011☝822,300 (100%)
2010☝789,620 (100%)
2009☝766,130 (100%)

2008👇745,180 (100%)
2007☝766,860 (100%)
2006☝720,280 (100%)
2005☝710,040 (100%)
2004☝699,560 (100%)
2003☝675,300 (100%)
2002
_-_637,500 (100%)
——————————————————————
Estimated New Prostate Cancer (Men)
——————————————————————
2013👇238,590 (28%)
2012☝241,470 (29%)
2011☝240,890 (29%)
2010☝217,730 (28%)
2009☝192,280 (25%)

2008👇186,320 (25%)
2007👇218,890 (29%)
2006☝234,460 (33%)
2005☝232,090 (33%)
2004☝230,110 (33%)
2003☝220,900 (33%)
2002
_-_189,000 (30%)
——————————————————————
Estimated New Lung and bronchus Cancer (Men)
——————————————————————
2013☝118,080 (14%)
2012☝116,470 (14%)

2011👇115,060 (14%)
2010☝116,750 (15%)
2009☝116,090 (15%)

2008👇114,690 (15%)
2007☝114,760 (15%)
2006👇92,700 (13%)
2005👇93,010 (13%)
2004☝93,110 (13%)
2003☝91,800 (14%)
2002
90,200 (14%)
——————————————————————
Estimated New Colon and rectum Cancer (Men)
——————————————————————
2013☝73,680 (13%)
2012☝73,420 (9%)

2011👇71,850 (9%)
2010👇72,090 (9%)
2009👇75,590 (10%)
2008👇77,250 (10%)
2007☝79,130 (10%)
2006☝72,800 (10%)

2005👇71,820 (10%)
2004☝73,620 (11%)
2003☝72,800 (11%)
2002
72,600 (11%)
——————————————————————
Estimated New Urinary bladder Cancer (Men)
——————————————————————
2013👇54,610 (6%)
2012☝55,600 (7%)
2011👇52,020 (6%)
2010👇52,760 (7%)
2009☝52,810 (7%)
2008☝51,230 (7%)
2007☝50,040 (7%)

2006👇44,690 (6%)
2005☝47,010 (7%)
2004☝44,640 (6%)
2003☝42,200 (6%)
2002
41,500 (7%)
——————————————————————
Estimated New Melanoma of the skin Cancer (Men)
——————————————————————
2013☝45,060 (5%)
2012☝44,250 (5%)
2011☝40,010 (5%)

2010👇38,870 (5%)
2009☝39,080 (5%)
2008☝34,950 (5%)

2007👇33,910 (4%)
2006☝34,260 (5%)
2005☝33,580 (5%)
2004 – 29,900 (4%)

2003👇29,900 (4%)
200230,100 (5%)
——————————————————————
Estimated New Kidney and renal pelvis Cancer (Men)
——————————————————————
2013☝40,430 (5%)
2012☝40,250 (5%)
2011☝37,120 (5%)

2010👇35,370 (4%)
2009☝35,430 (5%)
2008☝33,130 (4%)
2007☝31,590 (4%)
2006☝24,650 (3%)
2005☝22,490 (3%)
2004☝22,080 (3%)
2003☝19,500 (3%)
2002
19,100 (3%)
——————————————————————
Estimated New Non-Hodgkin lymphoma (Men)
——————————————————————
2013👇37,600 (4%)
2012☝38,160 (4%)
2011☝36,060 (4%)

2010👇35,380 (4%)
2009☝35,990 (5%)
2008☝35,450 (5%)
2007☝34,200 (4%)
2006☝30,680 (4%)
2005☝29,070 (4%)
2004☝28,850 (4%)
2003☝28,300 (4%)
2002
28,200 (4%)
——————————————————————
Estimated New Oral cavity and pharynx Cancer (Men)
——————————————————————
2013☝29,620 (3%)
2012☝28,540 (3%)
2011☝27,710 (3%)
2010☝25,420 (3%)

2009👇25,240 (3%)
2008☝25,310 (3%)
2007☝24,180 (3%)
2006☝20,180 (3%)
2005☝19,100 (3%)
2004☝18,550 (3%)

2003👇18,200 (3%)
200218,900 (3%)
——————————————————————
Estimated New Leukemia (Men)
——————————————————————
2013☝27,880 (3%)
2012☝26,830 (3%)
2011☝25,320 (3%)

2010👇24,690 (3%)
2009☝25,630 (3%)
2008☝25,180 (3%)
2007☝24,800 (3%)
2006☝20,000 (3%)
2005☝19,640 (3%)
2004☝19,020 (3%)
2003☝17,900 (3%)
2002
17,600 (3%)
——————————————————————
Estimated New Pancreas Cancer (Men)
——————————————————————
2013☝22,740 (3%)
2012☝22,090 (3%)
2011☝22,050 (3%)
2010☝21,370 (3%)
2009☝21,050 (3%)

2008👇18,770 (3%)
2007☝18,830 (2%)
2006☝17,150 (2%)
2005☝16,109 (2%)
2004☝15,740 (2%)
2003☝14,900 (2%)
2002
14,700 (2%)
======================================

20131113-231037.jpg

20131113-113632.jpg
——————————————————————
American Cancer Society
——————————————————————
Cancer Facts & Figures
======================================
REFERENCES:
======================================
[0] – AMERICAN CANCER SOCIETY

More Interested In Accumulating Wealth Than Saving Lives

Samuel S. Epstein, M.D.

Emeritus professor Environmental and Occupational Medicine

University of Illinois School of Public Health

and

Chairman, The Cancer Prevention Coalition
——————————————————————
http://www.wnho.net/acs.pdf
======================================
2013
——————————————————————

Click to access acspc-036845.pdf

——————————————————————

Click to access acspc-036845.pdf

——————————————————————
http://cancer.org/research/cancerfactsstatistics/cancerfactsfigures2013/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2013/index
——————————————————————
http://cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2013
——————————————————————
http://m.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2013
======================================
2012
——————————————————————

Click to access acspc-031941.pdf

——————————————————————

Click to access acspc-031941.pdf

——————————————————————
http://cancer.org/research/cancerfactsstatistics/cancerfactsfigures2012/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2012/index
——————————————————————
http://cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2012
——————————————————————
http://m.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2012
======================================
2011
——————————————————————

Click to access acspc-029771.pdf

——————————————————————

Click to access acspc-029771.pdf

——————————————————————
http://cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2011
——————————————————————
http://m.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2011
======================================
2010
——————————————————————

Click to access acspc-024113.pdf

——————————————————————

Click to access acspc-024113.pdf

——————————————————————
http://cancer.org/research/cancerfactsstatistics/cancerfactsfigures2010/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2010/index
======================================
2009
——————————————————————

Click to access 500809webpdf.pdf

——————————————————————

Click to access 500809webpdf.pdf

——————————————————————
http://cancer.org/research/cancerfactsstatistics/cancerfactsfigures2009/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2009/index
——————————————————————
http://cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2009
——————————————————————
http://m.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2009
======================================
2008
——————————————————————

Click to access worldcancer.pdf

——————————————————————
http://cancer.org/research/cancerfactsstatistics/cancerfactsfigures2008/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2008/index
——————————————————————
http://cancer.org/research/cancerfactsstatistics/allcancerfactsfigures/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/allcancerfactsfigures/index
======================================
2007
——————————————————————

Click to access caff2007pwsecuredpdf.pdf

——————————————————————

Click to access caff2007pwsecuredpdf.pdf

——————————————————————
http://cancer.org/research/cancerfactsstatistics/cancerfactsfigures2007/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2007/index
——————————————————————
http://cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2007
——————————————————————
http://m.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2007
======================================
2006
——————————————————————

Click to access caff2006pwsecuredpdf.pdf

——————————————————————

Click to access caff2006pwsecuredpdf.pdf

——————————————————————
http://cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2006
——————————————————————
http://m.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2006
======================================
2005
——————————————————————

Click to access caff2005f4pwsecuredpdf.pdf

——————————————————————

Click to access caff2005f4pwsecuredpdf.pdf

——————————————————————
http://cancer.org/research/cancerfactsstatistics/allcancerfactsfigures/index
——————————————————————
http://m.cancer.org/research/cancerfactsstatistics/allcancerfactsfigures/index
——————————————————————
http://cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2005
——————————————————————
http://m.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2005
======================================
2004
——————————————————————

Click to access CancerRates2004.pdf

======================================
2003
——————————————————————

Click to access 2003_ACS_Cancer_Facts.pdf

======================================
2002
——————————————————————

Click to access CancerFacts&Figures2002.pdf

======================================